Moreover, magnolol used in the treatment of colorectal cancer reduces the phosphorylation of protein kinase C delta type (PKCδ) and NF-κB, which are two proteins that are involved in tumour progression in vitro and in vivo [48]. Here, PRKCD is linked to neoplasm.